Stock BNKL BIONIK LABORATORIES CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bionik Laboratories Corp.

Equities

BNKL

US09074A2087

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets
Other stock markets
 08:10:00 2023-11-29 pm EST 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Bionik Laboratories Corp. -.--% -.--%
2023 Bionik Laboratories Corp. Announces Executive Changes CI
2023 Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 7.395 11.1 9.491 12.82 2.214 2.796
Enterprise Value (EV) 1 6.94 10.65 9.3 15.93 0.2224 4.781
P/E ratio -0.49 x -0.95 x -0.33 x -0.94 x -0.21 x -0.56 x
Yield - - - - - -
Capitalization / Revenue 7.49 x 3.42 x 4.41 x 10.7 x 1.74 x 1.55 x
EV / Revenue 7.03 x 3.28 x 4.32 x 13.3 x 0.17 x 2.65 x
EV / EBITDA -0.74 x -1.17 x -0.86 x -2.67 x -0.05 x -1.02 x
EV / FCF -17.2 x -0.78 x -1.73 x -4.45 x -0.08 x -3.02 x
FCF Yield -5.8% -127% -57.8% -22.5% -1,228% -33.1%
Price to Book 0.87 x 0.6 x 0.71 x 4.34 x 0.88 x -1.7 x
Nbr of stocks (in thousands) 689 2,612 5,130 5,128 5,903 6,990
Reference price 2 10.73 4.250 1.850 2.500 0.3750 0.4000
Announcement Date 6/27/18 7/1/19 6/30/20 6/24/21 6/9/22 6/21/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 0.9874 3.246 2.153 1.193 1.274 1.805
EBITDA 1 -9.356 -9.139 -10.78 -5.966 -4.67 -4.71
EBIT 1 -9.769 -9.487 -11.16 -6.155 -4.773 -4.773
Operating Margin -989.36% -292.28% -518.45% -515.76% -374.7% -264.4%
Earnings before Tax (EBT) 1 -14.63 -10.56 -25.02 -13.62 -10.41 -4.946
Net income 1 -14.63 -10.56 -25.02 -13.62 -10.41 -4.946
Net margin -1,481.2% -325.21% -1,161.75% -1,141.29% -817.14% -273.99%
EPS 2 -21.73 -4.467 -5.614 -2.656 -1.781 -0.7164
Free Cash Flow 1 -0.4023 -13.58 -5.378 -3.581 -2.73 -1.581
FCF margin -40.75% -418.29% -249.77% -300.1% -214.32% -87.58%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 6/27/18 7/1/19 6/30/20 6/24/21 6/9/22 6/21/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 3.11 - 1.98
Net Cash position 1 0.46 0.45 0.19 - 1.99 -
Leverage (Debt/EBITDA) - - - -0.5213 x - -0.4214 x
Free Cash Flow 1 -0.4 -13.6 -5.38 -3.58 -2.73 -1.58
ROE (net income / shareholders' equity) -65.6% -44.1% -123% -164% -335% -769%
ROA (Net income/ Total Assets) -21.2% -20% -28.4% -28.2% -44.3% -74.2%
Assets 1 68.93 52.75 88.19 48.33 23.49 6.663
Book Value Per Share 2 12.30 7.100 2.600 0.5800 0.4300 -0.2300
Cash Flow per Share 2 0.3000 0.1200 0.4400 0.1100 0.2900 0.0600
Capex 1 0.02 0.1 0.16 - 0.01 0.01
Capex / Sales 2.18% 3.14% 7.41% - 0.98% 0.48%
Announcement Date 6/27/18 7/1/19 6/30/20 6/24/21 6/9/22 6/21/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
BIONIK LABORATORIES CORP. Stock Bionik Laboratories Corp.
-.--% 12
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.79% 184B
MEDTRONIC PLC Stock Medtronic plc
-0.84% 108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.75% 67.82B
DEXCOM, INC. Stock DexCom, Inc.
+3.45% 51.05B
CENCORA, INC. Stock Cencora, Inc.
+9.04% 44.67B
HOYA CORPORATION Stock Hoya Corporation
+3.40% 41.78B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.21% 26.78B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.66% 26.59B
TERUMO CORPORATION Stock Terumo Corporation
+15.23% 25.86B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. BNKL Stock
  4. Financials Bionik Laboratories Corp.